Latest Press Releases

06.05.2013

Boehringer Ingelheim joins Structural Genomics Consortium - for further research into uncurable diseases

25.04.2013

Boehringer Ingelheim Announces a Strong 2012 Performance in China

24.04.2013

Boehringer Ingelheim consistently continues growth phase in financial year 2012

23.04.2013

Boehringer Ingelheim announces results from one of its HCV Phase III trials:
Investigational compound faldaprevir⁺ shows high viral cure and early treatment success in treatment-naïve patients with genotype-1
hepatitis C

-

For media outside USA, UK and Canada only

02.04.2013

Innovative treatment for canine epilepsy: European approval granted for Boehringer Ingelheim’s Pexion®